Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site

Vaccine

Volumn 27, Issue 1, 2009, Pages 93-98

  Rémond, Michelle ^a   Da Costa, Bruno ^b   Riffault, Sabine ^b   Parida, Satya ^c   Breard, Emmanuel ^a   Lebreton, Françoise ^a   Zientara, Stephan ^a   Delmas, Bernard ^b  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

FMDV epitope; IBDV; Vaccine

Indexed keywords

CAPSID PROTEIN; CHIMERIC PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN VP2; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; BIRD DISEASE; BIRNAVIRIDAE; BURSA FABRICII; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE VIRUS; GUMBORO DISEASE; IMMUNOGENICITY; INFECTIOUS BURSAL DISEASE VIRUS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SUBVIRAL PARTICLE; VIRUS LIKE AGENT;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; BACULOVIRIDAE; CAPSID; CAPSID PROTEINS; CATTLE; CELLS, CULTURED; EPITOPES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; INFECTIOUS BURSAL DISEASE VIRUS; MICE; MICE, INBRED BALB C; SPODOPTERA;

EID: 56949087041     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.036     Document Type: Article

References (28)

1. Delmas B., Kibenge F.S.B., Leong J.C., Mundt E., Vakharia V.N., and Wu J.L. Birnaviridae. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball A.L. (Eds). Virus taxonomy (2005), Academic Press, London 561-569
2. van den Berg T.P. Acute infectious bursal disease in poultry: a review. Avian Pathol 29 (2000) 175-194
3. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., et al. The Birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120 (2005) 761-772
4. Caston J.R., Martinez-Torrecuadrada J.L., Maraver A., Lombardo E., RodriguezJF, Casal J.I., et al. C terminal of IBDV major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol 75 (2001) 10815-10828
5. Letzel T., Coulibaly F., Rey F.A., Delmas B., Jagt E., van Loon A.A., et al. Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. J Virol 81 (2007) 12827-12835
6. Schnitzler D., Bernstein F., Muller H., and Becht H. The genetic basis for antigenicity of the VP2 protein of the IBDV. J Gen Virol 74 (1993) 1563-1571
7. Francis M.J., Hastings G.Z., Clarke B.E., Brown A.L., Beddell C.R., Rowlands D.J., et al. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus. Immunology 69 (1990) 171-176
8. Zamorano P.I., Wigdorovitz A., Perez Filgueira D.M., Escribano J.M., Sadir A.M., and Borca M.V. Induction of anti foot-and-mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Vaccine 16 (1998) 558-563
9. Pfaff E., Thiel H.J., Beck E., Strohmaier K., and Schaller H. Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Gen Virol 62 (1988) 2033-2040
10. Chevalier C., Lepault J., Erk I., Da Costa B., and Delmas B. The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids. J Virol 76 (2002) 2384-2392
11. Chevalier C., Lepault J., Da Costa B., and Delmas B. The last C-terminal residue of VP3, glutamic acid 257, controls capsid assembly of infectious bursal disease virus. J Virol 78 (2004) 3296-3303
12. de Haan L., Verweij W., Agsteribbe E., and Wilschut J. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat labile enterotoxin and Virio cholerae cholera toxin. Cell Biol 76 (1998) 270-279
13. Xie Q.C., McCahon D., Crowther J.R., Belsham G.J., and McCullough K.C. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol 68 (1987) 1637-1647
14. Mackay D.K., Bulut A.N., Rendle T., Davidson F., and Ferris N.P. A solid phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods 97 (2001) 33-48
15. Rueda P., Hurtado A., del Barrio M., Martinez-Torrecuadrada J.L., Kamstrup S., Leclerc C., et al. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles. Virology 263 (1999) 89-99
16. Chackerian B., Lowy D.R., and Schiller J.T. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. Proc Natl Acad Sci USA 96 (1999) 2373-2378
17. Chackerian B., Lowy D.R., and Schiller J.T. Conjugation of a self-antigen to papillomavirus-like particles allow for efficient induction of protective antibodies. J Clin Invest 08 (2001) 415-423
18. Sadeyen J.R., Tourne S., Shkreli M., Sizaret P.Y., and Coursaget P. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope. Virology 309 (2003) 32-40
19. Zhang Y.L., Guo Y.J., Wang K.Y., Lu K., Li K., Zhu Y., et al. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multi epitopes of foot-and-mouth disease virus. J Immunol 65 (2007) 20-328
20. Kratz P.A., Böttcher B., and Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 96 (1999) 1915-1920
21. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., king A., et al. Structure of a major antigenic site on foot-and-mouth disease virus. Nature 362 (1993) 566-568
22. Kitson J.D.A., Burke K.L., Pullen L.A., Belsham G.J., and Almond J.W. Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea-pigs. J Virol 65 (1991) 3068-3075
23. Benito A., Mateu M.G., and Villaverde A. Improved mimicry of a foot-and-mouth disease virus antigenic site by a viral peptide displayed on β-galactosidase surface. Biotechnology 13 (1995) 801-804
24. Wang C.Y., Chang T.Y., Walfield A.M., Ye J., Shen M., Chen S.P., et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20 (2002) 2603-2610
25. Bachman M.F., Rohrer U.H., Kundig T.M., Burki K., Hengartner H., and Zinkernagel R.M. The influence of antigen organization on B cells responsiveness. Science 5138 (1993) 1448-1451
26. Parry N.R., Ouldridge E.J., Barnett P.V., Clarke B.E., Francis M.J., Fox J.D., et al. Serological prospects for peptide vaccines against foot-and-mouth disease virus. J Gen Virol 70 (1989) 2919-2930
27. Barnett P.V., Pullen L., Staple R.F., Lee L.J., Butcher R., Parkinson D., et al. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence. J Gen Virol 77 (1996) 1011-1018
28. Chénard G., Miedema K., Moonen P., Schrijver R.S., and Dekker A. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J Virol Methods 107 (2003) 89-98